Linked Data API

Show Search Form

Search Results

750552
registered interest false more like this
date less than 2017-07-11more like thismore than 2017-07-11
answering body
Department of Health more like this
answering dept id 17 more like this
answering dept short name Health more like this
answering dept sort name Health more like this
hansard heading General Practitioners more like this
house id 2 remove filter
legislature
25277
pref label House of Lords more like this
question text Her Majesty's Government what assessment they have made of the chronic fatigue syndrome myalgic encephalomyelitis (ME/CFS) clinical services which were set up between 2004 and 2006; what proportion of patients accessing services recover from ME/CFS or show signs of improvement; and what assessment they have made of the value for money of these services. more like this
tabling member printed
The Countess of Mar more like this
uin HL684 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2017-07-19more like thismore than 2017-07-19
answer text <p>No central assessment has been made of chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME) clinical services established between 2004 and 2006. The commissioning of services for people with CFS/ME is a local matter, and the management of patients within such services is the responsibility of the commissioners, providers and clinicians responsible for their care. Clinical commissioning groups have a duty to exercise their functions effectively, efficiently and economically</p><p> </p><p>Since its publication in 2007, the National Institute for Health and Care Excellence (NICE) clinical guideline on the management of CFS/ME in adults and children, which set outs best practice on the care, treatment and support of people with the condition, has supported the local National Health Service in delivering services for people with the condition. The guidance recognises the challenges in managing a condition for which there is no definitive diagnostic test, no clear understanding of the causes and process of disease and no cure. The guidance is also clear that there is no one form of treatment to suit every patient and that treatment and care should take into account the personal needs and preferences of the patient. NICE is currently reviewing the guidance to ensure it reflects the latest available evidence and a decision regarding this matter is expected shortly.</p><p><br></p>
answering member printed Lord O'Shaughnessy more like this
question first answered
less than 2017-07-19T11:03:01.517Zmore like thismore than 2017-07-19T11:03:01.517Z
answering member
4545
label Biography information for Lord O'Shaughnessy more like this
tabling member
1861
label Biography information for The Countess of Mar more like this